ask="0.5400"
ask_size="1000"
average_daily_volume="832508"
bid="0.4750"
bid_size="1000"
book_value="-0.4130"
change="-0.0201"
change_from_200_day_moving_average="-0.1887"
change_from_50_day_moving_average="-0.0853"
change_from_52_week_high="-0.9901"
change_From_52_week_low="0.2599"
change_in_percent="-3.7222%"
close="0.5199"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0830"
ebitda="-1.60M"
eps_estimate_current_year="-0.0800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0300"
ex_dividend_date="N/A"
float_shares="133560000"
high="0.5500"
high_52_weeks="1.5100"
last_trade_date="2/3/2017"
last_trade_price="0.5199"
last_trade_size="902"
last_trade_time="4:02pm"
low="0.5107"
low_52_weeks="0.2600"
market_capitalization="80.84M"
moving_average_200_day="0.7086"
moving_average_50_day="0.6052"
name="Navidea Biopharmaceuticals
Inc"
notes="N/A"
one_year_target_price="1.2500"
open="0.5400"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-26.6334%"
percent_change_from_50_day_moving_average="-14.0877%"
percent_change_from_52_week_high="-65.5695%"
percent_change_from_52_week_low="+99.9616%"
previous_close="0.5400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.6654"
revenue="22.91M"
shares_outstanding="155494000"
short_ratio="17.2000"
stock_exchange="ASE"
symbol="NAVB"
volume="512761"
weeks_range_52="0.2600 - 1.5100"
